[go: up one dir, main page]

ES8707974A1 - Procedimiento para la obtencion de un peptido - Google Patents

Procedimiento para la obtencion de un peptido

Info

Publication number
ES8707974A1
ES8707974A1 ES550911A ES550911A ES8707974A1 ES 8707974 A1 ES8707974 A1 ES 8707974A1 ES 550911 A ES550911 A ES 550911A ES 550911 A ES550911 A ES 550911A ES 8707974 A1 ES8707974 A1 ES 8707974A1
Authority
ES
Spain
Prior art keywords
peptide
obtaining
procedure
peptidoamide
protective groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES550911A
Other languages
English (en)
Other versions
ES550911A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES550911A0 publication Critical patent/ES550911A0/es
Publication of ES8707974A1 publication Critical patent/ES8707974A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57527—Calcitonin gene related peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

METODO DE OBTENER UN PEPTIDO. CONSISTE EN DISOCIAR LOS GRUPOS PROTECTORES DE PEPTIDOAMIDA O N-ACILADO DE UNA PEPTIDOAMIDA, EN UN MEDIO SOLVOLITICO, ENTRE 0 Y 50JC, PARA OBTENER UN PEPTIDO DE FORMULA (I) Y SUS SALES FARMACEUTICAMENTE ACEPTABLES. LOS RESTOS DE CISTEINA DESARROLLAN FUENTES DE DISULFURO INTRAMOLECULARES, Y LOS GRUPOS PROTECTORES PROTEGEN A LOS GRUPOS FUNCIONALES. SE UTILIZAN EN EL SECTOR FARMACEUTICO COMO COMPUESTOS INTERMEDIOS.
ES550911A 1985-01-16 1986-01-15 Procedimiento para la obtencion de un peptido Expired ES8707974A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH18885 1985-01-16

Publications (2)

Publication Number Publication Date
ES550911A0 ES550911A0 (es) 1987-09-01
ES8707974A1 true ES8707974A1 (es) 1987-09-01

Family

ID=4181264

Family Applications (2)

Application Number Title Priority Date Filing Date
ES550911A Expired ES8707974A1 (es) 1985-01-16 1986-01-15 Procedimiento para la obtencion de un peptido
ES557315A Expired ES8802161A1 (es) 1985-01-16 1987-01-14 Procedimiento para la obtencion de peptidos

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES557315A Expired ES8802161A1 (es) 1985-01-16 1987-01-14 Procedimiento para la obtencion de peptidos

Country Status (12)

Country Link
US (1) US4720483A (es)
EP (1) EP0188400B1 (es)
JP (1) JPH0780908B2 (es)
AT (1) ATE78040T1 (es)
CA (1) CA1339365C (es)
DE (1) DE3685885D1 (es)
DK (1) DK17986A (es)
ES (2) ES8707974A1 (es)
FI (1) FI86547C (es)
GR (1) GR860081B (es)
IE (1) IE58190B1 (es)
PT (1) PT81837B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5221518A (en) * 1984-12-14 1993-06-22 Mills Randell L DNA sequencing apparatus
GB8720115D0 (en) * 1987-08-26 1987-09-30 Cooper G J S Treatment of diabetes mellitus
EP0373260B1 (en) * 1987-06-22 1994-03-09 Merck & Co. Inc. Cyclosporin derivatives with modified "8-amino acid"
US5266561A (en) * 1988-01-11 1993-11-30 Amylin Pharmaceuticals, Inc. Treatment of type 2 diabetes mellitus
US5153308A (en) * 1988-06-16 1992-10-06 Teijin Limited S-sulfonated calcitonin derivatives
US5175145A (en) * 1988-08-26 1992-12-29 Amylin Pharmaceuticals, Inc. Treatment of diabetes mellitus with amylin agonists
GB8829432D0 (en) * 1988-12-15 1989-02-01 Celltech Ltd Enzymatic process
EP0448513A3 (en) * 1990-03-21 1991-12-27 Japat Ltd Process for production of peptidylglycine alpha-hydroxylating monooxygenase and use thereof
DE69227517D1 (de) * 1991-08-08 1998-12-10 Amylin Pharmaceuticals Inc Produktion von peptid-amiden
US5569604A (en) * 1993-09-03 1996-10-29 The University Of Iowa Research Foundation Calcitonin/calcitonin gene related peptide enhancer element and associated DNA binding proteins
US5898031A (en) * 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA
US20050042647A1 (en) * 1996-06-06 2005-02-24 Baker Brenda F. Phosphorous-linked oligomeric compounds and their use in gene modulation
US20040203024A1 (en) * 1996-06-06 2004-10-14 Baker Brenda F. Modified oligonucleotides for use in RNA interference
US20050053976A1 (en) * 1996-06-06 2005-03-10 Baker Brenda F. Chimeric oligomeric compounds and their use in gene modulation
US20040171031A1 (en) * 1996-06-06 2004-09-02 Baker Brenda F. Sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
US20050119470A1 (en) * 1996-06-06 2005-06-02 Muthiah Manoharan Conjugated oligomeric compounds and their use in gene modulation
US20040147022A1 (en) * 1996-06-06 2004-07-29 Baker Brenda F. 2'-methoxy substituted oligomeric compounds and compositions for use in gene modulations
US7812149B2 (en) * 1996-06-06 2010-10-12 Isis Pharmaceuticals, Inc. 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
US9096636B2 (en) * 1996-06-06 2015-08-04 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
EP0920327A1 (en) * 1996-08-15 1999-06-09 Southern Illinois University Enhancement of antimicrobial peptide activity by metal ions
DE19652033A1 (de) * 1996-12-13 1998-06-18 Irmgard Dr Med Guertner Neuropeptid (CGRP) als Modulator zur Zelldifferenzierung und Proliferation
WO2004044139A2 (en) * 2002-11-05 2004-05-27 Isis Parmaceuticals, Inc. Modified oligonucleotides for use in rna interference
EP1636342A4 (en) * 2003-06-20 2008-10-08 Isis Pharmaceuticals Inc OLIGOMER COMPOUNDS FOR USE IN THE MODULATION OF GENES
CA2552757A1 (en) * 2004-01-13 2005-08-04 Vasogenix Pharmaceuticals, Inc. Methods of using cgrp for cardiovascular and renal indications
EP1703916A2 (en) * 2004-01-13 2006-09-27 Vasogenix Pharmaceuticals, Inc. Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same
WO2005067890A2 (en) * 2004-01-13 2005-07-28 Vasogenix Pharmaceuticals, Inc. Controlled release cgrp delivery composition for cardiovascular and renal indications
US8569474B2 (en) * 2004-03-09 2013-10-29 Isis Pharmaceuticals, Inc. Double stranded constructs comprising one or more short strands hybridized to a longer strand
US8394947B2 (en) * 2004-06-03 2013-03-12 Isis Pharmaceuticals, Inc. Positionally modified siRNA constructs
WO2005121372A2 (en) * 2004-06-03 2005-12-22 Isis Pharmaceuticals, Inc. Double strand compositions comprising differentially modified strands for use in gene modulation
US7884086B2 (en) * 2004-09-08 2011-02-08 Isis Pharmaceuticals, Inc. Conjugates for use in hepatocyte free uptake assays
US8168592B2 (en) * 2005-10-21 2012-05-01 Amgen Inc. CGRP peptide antagonists and conjugates
JP4884193B2 (ja) * 2006-12-15 2012-02-29 ヤマハ発動機株式会社 船舶
CN102666579A (zh) 2009-10-30 2012-09-12 诺沃—诺迪斯克有限公司 降钙素基因相关肽的衍生物
EP2748325A4 (en) * 2011-08-22 2015-04-01 Suganit Systems Inc PREPARATION OF BIOBUTANOL AND RELATED PRODUCTS
WO2025196125A1 (en) * 2024-03-19 2025-09-25 Epoqe Pharma Aps N-terminally modified calcitonin gene-related peptide analogues

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE134631T1 (de) * 1983-06-15 1985-12-05 Roger Kingdom Craig Peptide, pharmazeutische zusammensetzungen, gene, vektoren, wirtorganismen, verfahren zu deren herstellung und diagnostische reagenzien.
US4530838A (en) * 1983-07-08 1985-07-23 The Salk Institute For Biological Studies Synthetic calcitonin-gene-related peptides for lowering blood pressure or gastric acid secretion in mammals
GB8327346D0 (en) * 1983-10-12 1983-11-16 Morris H R Peptide
US4549986A (en) * 1983-12-23 1985-10-29 The Salk Institute For Biological Studies Human CGRP

Also Published As

Publication number Publication date
JPS61172899A (ja) 1986-08-04
PT81837B (pt) 1988-05-27
DK17986A (da) 1986-07-17
FI860153L (fi) 1986-07-17
GR860081B (en) 1986-04-29
EP0188400B1 (de) 1992-07-08
ES550911A0 (es) 1987-09-01
ES8802161A1 (es) 1988-04-01
IE58190B1 (en) 1993-07-28
ATE78040T1 (de) 1992-07-15
PT81837A (en) 1986-02-01
US4720483A (en) 1988-01-19
EP0188400A3 (en) 1988-08-31
DE3685885D1 (de) 1992-08-13
FI860153A0 (fi) 1986-01-13
ES557315A0 (es) 1988-04-01
CA1339365C (en) 1997-08-26
EP0188400A2 (de) 1986-07-23
FI86547C (fi) 1992-09-10
JPH0780908B2 (ja) 1995-08-30
FI86547B (fi) 1992-05-29
DK17986D0 (da) 1986-01-15
IE860116L (en) 1986-07-16

Similar Documents

Publication Publication Date Title
ES8707974A1 (es) Procedimiento para la obtencion de un peptido
SE8602723L (sv) Tiazoler, deras framstellning och farmaceutiska kompositioner innehallande dem
ES2108425T3 (es) Analogos de atp sustituidos con n-alquilo-2.
AR008377A1 (es) Un compuesto derivado de la 3-aroilbencilpiridazinona, una composicion farmaceutica particularmente para el tratamiento de enfermedades inflamatorias o autoinmunes que contiene dicho compuesto
ES2058527T3 (es) Derivados de pirimidina condensados procedimiento y compuestos intermedios para su preparacion y composiciones farmaceuticas que los contienen.
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
ES2076935T3 (es) Compuesto de pirazolopiridina y procedimientos para su preparacion.
ES2062395T3 (es) Nuevos compuestos de bencimidazol y su uso.
ES2169105T3 (es) Agentes antitromboticos tripeptidicos.
ES2054860T3 (es) Nuevos derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion, asi como a su utilizacion como medicamentos.
ES2072959T3 (es) Derivados de aminoacido.
MX9304360A (es) Derivados de rapamicina y composiciones farmaceuticas de los mismos.
ES2150577T3 (es) Aminoeteres aromaticos como agentes para aliviar el dolor.
ES2147230T3 (es) Derivados de aminoacidos, medicamentos que contienen a estos compuestos y procedimiento para su preparacion.
ES8602022A1 (es) Un procedimiento para preparar un derivado de 4'-dimetil-4-epipodofilotoxina
ES2178055T3 (es) Derivados aminicos substituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
PT83535B (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados de aminoacidos
ES2043665T3 (es) 6,11-dihidro-11-(4-piperidiliden)-5h-benzo-(5,6)-ciclohepta-(1,2-b)-piridinas y composiciones y metodos de uso.
ES452200A1 (es) Un procedimiento para la preparacion de nuevos derivados de pipendina.
ES2001978A6 (es) Un procedimiento nuevo para la preparacion de analogos de 7-amino-mitosano
ES8406461A1 (es) Procedimiento para la obtencion de benzofuranonas
ES2167021T3 (es) Derivados de acido 4-bifenil-4-hidroxibutirico sustituidos como inhibidores de metaloproteasa de matriz.
ES2135722T3 (es) 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina.
ES2032752T3 (es) Procedimiento de preparacion de derivados de la 1-bencenosulfonil-2-oxo-5-alcoxi-pirrolidina.
MX9301404A (es) Derivados de 2-oxoquinolina, procedimiento para su preparacion, preparado farmaceutico que los contiene y procedimiento para la obtencion de tal preparado farmaceutico.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970612